| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 12.358 | 72.160 | 127.769 | 209.250 | 235.938 |
| Total Income - EUR | - | - | - | - | - | 12.359 | 72.163 | 127.811 | 213.003 | 235.958 |
| Total Expenses - EUR | - | - | - | - | - | 4.239 | 53.951 | 111.997 | 191.868 | 219.161 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.121 | 18.212 | 15.814 | 21.136 | 16.797 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.003 | 17.630 | 14.640 | 19.455 | 11.617 |
| Employees | - | - | - | - | - | 1 | 2 | 3 | 6 | 6 |
Check the financial reports for the company - Evermicaden S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 442 | 1.998 | 0 | 35.451 | 26.310 |
| Current Assets | - | - | - | - | - | 8.317 | 25.247 | 20.014 | 19.490 | 34.040 |
| Inventories | - | - | - | - | - | 0 | 0 | 1.831 | 2.094 | 2.082 |
| Receivables | - | - | - | - | - | 210 | 1.341 | 1.851 | 8.219 | 10.838 |
| Cash | - | - | - | - | - | 8.107 | 23.906 | 16.332 | 9.178 | 21.120 |
| Shareholders Funds | - | - | - | - | - | 8.044 | 25.496 | 14.867 | 27.685 | 39.147 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 714 | 1.749 | 5.146 | 29.522 | 23.166 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Evermicaden S.r.l.